FIELD: veterinary.
SUBSTANCE: claimed method includes application of chimera flavivirus, including capsid and non-structural proteins of yellow fever virus, prM protein, and envelope protein of West Nile encephalitis virus as drug for prophylaxis of infection caused by West Nile virus in horses.
EFFECT: prophylaxis of infection caused by West Nile virus in horses.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
INACTIVATED CHIMERIC VACCINES AND RELATED METHODS OF APPLICATION | 2006 |
|
RU2436591C2 |
VACCINE AGAINST VIRUS OF WEST NILE ENCEPHALITIS | 2003 |
|
RU2376374C2 |
RECOMBINANT FLAVIVIRAL VACCINES | 2006 |
|
RU2465326C2 |
CHIMERIC FLAVIVIRAL VACCINES | 1998 |
|
RU2209082C2 |
FLAVIVIRUS WITH BIPARTITE GENOME AND USING IT | 2008 |
|
RU2527891C2 |
LYOPHILISED COMPOSITION FOR INDUCING IMMUNE RESPONSE TO FLAVIVIRUS, COMPOSITION AND METHOD FOR PREPARING IT | 2007 |
|
RU2541784C2 |
RECOMBINANT PLASMID VECTOR pET32-WNV-DIII, PROVIDING SYNTHESIS AND SECRETION OF RECOMBINANT DOMAIN III OF STRUCTURAL GLYCOPROTEIN E OF WEST NILE VIRUS IN ESCHERICHIA COLI CELLS, ESCHERICHIA COLI BL21(DE3)-DIII-WNV CELL LINE STRAIN AND DIII-WNV RECOMBINANT PROTEIN FOR PREPARING IMMUNOBIOLOGICAL PREPARATIONS | 2024 |
|
RU2821341C1 |
IMMUNOBIOLOGICAL AGENT FOR THE PREVENTION OF DISEASES CAUSED BY TICK-BORNE ENCEPHALITIS VIRUS BASED ON A RECOMBINANT VIRUS OF THE GENUS FLAVIVIRUS | 2022 |
|
RU2795800C1 |
METHOD AND AGENT ACTIVATING IRF-3 FOR TREATING AND PREVENTING DISEASES CAUSED BY (+) RNA CONTAINING VIRUSES | 2012 |
|
RU2518314C2 |
CHIMERIC VACCINES BASED ON VIRUSES OF FLAVIVIRUS AND LYSSAVIRUS GENES | 2019 |
|
RU2816136C2 |
Authors
Dates
2007-12-27—Published
2002-10-21—Filed